3D Printing services, product reviews,market estimates forecasts, stocks

Stratasys is helping nasal swabs and COVID-19 testing

Posted on Updated on

According to Aaron Pearson, he is Vice President of Public Relations at Stratasys 3D Printing, “The need for widespread COVID-19 testing of millions of people has surfaced another shortage, nasal swabs. Stratasys has added to its efforts to fight the pandemic and ongoing testing requirements by marketing and promoting Origin 3D-printed nasopharyngeal (NP) swabs to healthcare providers and other testing centers in the U.S. The Origin 3D-printed nasopharyngeal swab has been tested in a clinical trial and is considered an FDA Class I Exempt Device.”

 

Nasal swabs and COVID-19 testing: the next step in the Stratasys pandemic response.

The benefit of 3D printing material

Posted on Updated on

As stated by Executive Vice President, Product Management, SYNNEX Corporation, David Dennis, “ESTANE® 3D TPU M95A TPU’s versatility, durability and barrier properties coupled with the leading 3D printing technology from HP bring extraordinary value in these vital applications. ESTANE® 3D TPU M95A TPU will benefit product designers who are developing applications that require skin contact, including personal protection equipment.”